移植后CD34+选择的干细胞增强作为干预手段，用于患有镰状细胞病的儿童和年轻成人在减低强度预处理异基因干细胞移植后混合嵌合体下降的情况：病例系列 - Suppr | 超能文献

Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series.

作者信息

Ngwube Alexander, Franay Cara, Shah Niketa

机构信息

Phoenix Children's Hospital, Phoenix, AZ, USA.

Yale University and Yale New Haven Children's Hospital, New Haven, CT, USA.

出版信息

Pediatr Hematol Oncol. 2022 Aug;39(5):475-480. doi: 10.1080/08880018.2021.2013369. Epub 2022 Feb 11.

DOI:10.1080/08880018.2021.2013369

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults with sickle cell disease: A case series.移植后CD34+选择的干细胞增强作为干预手段，用于患有镰状细胞病的儿童和年轻成人在减低强度预处理异基因干细胞移植后混合嵌合体下降的情况：病例系列

Pediatr Hematol Oncol. 2022 Aug;39(5):475-480. doi: 10.1080/08880018.2021.2013369. Epub 2022 Feb 11.

2

Post-Transplant CD34 Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.移植后 CD34 选择的干细胞“增强”对原发性免疫缺陷儿童和年轻成人接受低强度预处理的造血干细胞移植后混合嵌合体。

Biol Blood Marrow Transplant. 2018 Jul;24(7):1527-1529. doi: 10.1016/j.bbmt.2018.03.013. Epub 2018 Mar 16.

3

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.非清髓性 HLA 匹配同胞供体异基因造血干细胞移植治疗严重镰状细胞表型。

JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192.

4

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.异体造血干细胞移植治疗镰状细胞病。

N Engl J Med. 2009 Dec 10;361(24):2309-17. doi: 10.1056/NEJMoa0904971.

5

Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease.镰状细胞病患者接受匹配相关供体同种异体移植后稳定混合嵌合体患者的体外免疫评估。

Cytotherapy. 2019 Dec;21(12):1206-1215. doi: 10.1016/j.jcyt.2019.10.003. Epub 2019 Nov 26.

6

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.基于氟达拉滨的预处理方案用于成年镰状细胞病患者的异基因移植。

Bone Marrow Transplant. 2000 Aug;26(4):445-9. doi: 10.1038/sj.bmt.1702518.

7

CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.CD34选择的干细胞增强疗法用于镰状细胞病异基因移植后晚期移植物排斥反应的治疗。

Bone Marrow Transplant. 2022 Oct;57(10):1592-1594. doi: 10.1038/s41409-022-01749-9. Epub 2022 Jul 7.

8

Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.异基因造血干细胞移植治疗镰状细胞病。

Pediatr Blood Cancer. 2012 Aug;59(2):372-6. doi: 10.1002/pbc.24177. Epub 2012 Apr 27.

9

Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.混合供受者嵌合体与造血细胞移植治疗镰状细胞病后疾病复发的关系。

Biol Blood Marrow Transplant. 2017 Dec;23(12):2178-2183. doi: 10.1016/j.bbmt.2017.08.038. Epub 2017 Sep 4.

10

Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.治疗方法：在镰状细胞病中，使用清髓性、减强度和非清髓性预处理，进行来自匹配相关供体的同种异体造血细胞移植。

Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25.

引用本文的文献

1

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease.跨越清髓谱系：镰状细胞病儿科患者的造血细胞移植预处理方案

J Clin Med. 2022 Jul 3;11(13):3856. doi: 10.3390/jcm11133856.